(Q34148048)

31 July 2017

Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia (English)

1 reference

cognitive behavioral therapy

31 July 2017

0 references

0 references

1 reference

Henny A Westra

1

1 reference

PubMed ID

12214810

31 July 2017

Sheffy H Stewart

series ordinal

2

1 reference

PubMed ID

12214810

31 July 2017

Brent E Conrad

series ordinal

3

1 reference

31 July 2017

1 January 2002

1 reference

Journal of Anxiety Disorders

31 July 2017

1 reference

31 July 2017

16

1 reference

31 July 2017

233-246

1 reference

31 July 2017

3

1 reference

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

An inventory for measuring clinical anxiety: psychometric properties

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Tranquillising memories: a review of the effects of benzodiazepines on human memory

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Benzodiazepines, memory and mood: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Brief standard self-rating for phobic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Enhanced Relief of Phobias by Flooding During Waning Diazepam Effect

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Automaticity and the anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Clinical aspects of chronic use of alprazolam and lorazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Standardized assessment for panic disorder research. A conference report

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Behaviour therapy and benzodiazepines: allies or antagonists?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

As-needed use of benzodiazepines in managing clinical anxiety: incidence and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

A meta-analysis of treatments for panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2802%2900091-9

7 January 2021

10.1016/S0887-6185(02)00091-9

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12214810